Fuertes, Samuel B.

HRN: 25-45-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/14/2025
06/21/2025
IV
600mg
Q8
Gangrenous Left Foot
Waiting Final Action 
06/14/2025
CEFTRIAXONE 1G (VIAL)
06/14/2025
06/21/2025
IV
2 Grams
Q24
Grangrenous L Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: